Balentine LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.

Quarter-by-quarter ownership
Balentine LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$1,778,000
+72.5%
40,843
+72.5%
0.06%
+85.7%
Q1 2022$1,031,000
+62.6%
23,677
+64.8%
0.04%
+59.1%
Q4 2021$634,000
+91.0%
14,367
+65.2%
0.02%
+69.2%
Q3 2021$332,000
+52.3%
8,699
+58.8%
0.01%
+44.4%
Q2 2021$218,000
+101.9%
5,478
+106.6%
0.01%
+50.0%
Q2 2020$108,000
+134.8%
2,651
+147.5%
0.01%
+100.0%
Q3 2019$46,000
+7.0%
1,0710.0%0.00%0.0%
Q2 2019$43,000
-12.2%
1,071
-8.0%
0.00%0.0%
Q1 2019$49,000
+88.5%
1,164
+72.4%
0.00%
+50.0%
Q4 2018$26,000
-3.7%
6750.0%0.00%0.0%
Q3 2018$27,000
-27.0%
675
-26.6%
0.00%
-33.3%
Q2 2018$37,000
+131.2%
920
+127.2%
0.00%
+200.0%
Q1 2018$16,000
-91.4%
405
-92.3%
0.00%
-93.3%
Q4 2017$185,000
-37.5%
5,226
-28.4%
0.02%
-40.0%
Q3 2017$296,000
+26.0%
7,301
+34.2%
0.02%
+19.0%
Q2 2017$235,000
+2.6%
5,4390.0%0.02%
-4.5%
Q1 2017$229,000
+21.8%
5,439
+11.6%
0.02%
+10.0%
Q4 2016$188,000
-71.3%
4,873
-67.9%
0.02%
-77.8%
Q3 2016$655,000
+210.4%
15,188
+211.7%
0.09%
+114.3%
Q2 2016$211,000
+44.5%
4,873
+35.0%
0.04%
+13.5%
Q1 2016$146,0000.0%3,6100.0%0.04%
+23.3%
Q4 2015$146,000
+32.7%
3,610
+26.3%
0.03%
+50.0%
Q3 2015$110,000
+0.9%
2,858
+9.5%
0.02%
+11.1%
Q2 2015$109,000
-31.9%
2,610
-24.7%
0.02%
-40.0%
Q1 2015$160,0003,4650.03%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders